The differential expression of PFKM, GAPDH, ACO2, and MDH2 in the urinary exosomes of diabetic patients can serve as potential biomarkers for diabetes monitoring, providing a promising method for noninvasive diabetes diagnosis. This evidence concerns the gene PFKM and diabetes mellitus.